MECHANISMS OF SIGNAL TRANSDUCTION
Signaling Role of Intracellular Iron in NF-κB Activation*

https://doi.org/10.1074/jbc.M210905200Get rights and content
Under a Creative Commons license
open access

Iron chelators inhibit endotoxin-induced NF-κB activation in hepatic macrophages (HMs), suggesting a role for the intracellular chelatable pool of iron in NF-κB activation. The present study tested this hypothesis. Analysis of Fe59-loaded HMs stimulated with lipopolysaccharide (LPS), revealed a previously unreported, transient rise in intracellular low molecular weight (LMW)·Fe59complex ([LMW·Fe]i) at ≤2 min returning to the basal level within 15 min. The [LMW·Fe]i response preceded IκB kinase (IKK) (≥15 min) and NF-κB (≥30 min) activation. Iron chelators (1,2-dimethyl-3-hydroxypyridin-4-one andN,N′-bis-2-hydroxybenzylethylenediamine-N,N′-diacetic acid) abrogated the [LMW·Fe]i response and IKK and NF-κB activation. The [LMW·Fe]i response was also observed in tumor necrosis factor α (TNFα)-stimulated HMs and RAW264.7 cells treated with LPS and interferon-γ but not in primary rat hepatocytes or myofibroblastic cells exposed to LPS or TNFα. Both [LMW·Fe]i response and IKK activation in LPS-stimulated HMs were inhibited by diphenylene iodonium (nonspecific inhibitor for flavin-containing oxidases),l-N6-(1-iminoethyl)lysine (selective iNOS inhibitor), and adenoviral-mediated expression of a dominant negative mutant of Rac1 or Cu,Zn-superoxide dismutase, suggesting the role of NO and O2 in mediating the iron signaling. In fact, this inhibition was recapitulated by a cell-permeable scavenger of ONOO, 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinato iron (III) chloride. Conversely, ONOO alone induced both [LMW·Fe]i response and IKK activation. Finally, direct addition of ferrous iron to cultured HMs activated IKK and NF-κB. These results support a novel signaling role for [LMW·Fe]iin IKK activation, which appears to be induced by ONOOand selectively operative in macrophages.

Cited by (0)

Published, JBC Papers in Press, March 11, 2003, DOI 10.1074/jbc.M210905200

*

This work was supported in part by National Institutes of Health Grants R37AA06603, P50AA11999 (USC-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases), P30DK48522 (USC Research Center for Liver Diseases), and R24AA12885 (Non-parenchymal Liver Cell Core) and by the Medical Research Service of the Department of Veterans Affairs.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

FNb

Both authors contributed equally to this work.

FNc

Supported by Cooley's Anemia Foundation Postdoctoral award.

FNd

Supported by National Institute on Alcohol Abuse and Alcoholism Institutional Training Grant T32-AA07578.